By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Dana-Farber Cancer Institute 

44 Binney Street

Boston  Massachusetts  02115  U.S.A.
Phone: 617-632-3000 Fax: n/a


SEARCH JOBS
The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Vision

Dana-Farber Cancer Institute's ultimate goal is the eradication of cancer, AIDS, and related diseases and the fear that they engender.

Core Values

Impact

Above all else, we make a difference by relieving the burden of disease now and for the future through our research, clinical care, education, outreach and advocacy.

Excellence
We pursue excellence relentlessly and with integrity in all that we do, adhering always to the highest standards of conduct.

Compassion and Respect
For those in our care and for one another.

Discovery
We foster the spirit of inquiry, promoting collaboration and innovation across traditional boundaries while celebrating individual creativity.

www.Dana-FarberCareers.com


Key Statistics


Email: Dana-FarberContactUs@dfci.harvard.edu
Ownership: Private

Web Site: Dana-Farber Cancer Institute
Employees:
Symbol: 
 









Company News
Dana-Farber Cancer Institute And Astellas Pharma Inc. (ALPMY) Announce Research Collaboration 11/4/2014 7:21:32 AM
Dana-Farber Cancer Institute Researchers Identify Early Sign Of Pancreatic Cancer 9/29/2014 6:45:23 AM
Johnson & Johnson (JNJ), Dana-Farber Cancer Institute Launch $10 Million Lung Cancer Collaboration 6/24/2014 7:09:02 AM
TrovaGene, Inc. Announces Clinical Collaboration With Dana-Farber Cancer Institute 6/16/2014 7:02:25 AM
Drug Combination Extends Survival By More Than A Year In Metastatic Prostate Cancer, Dana-Farber Cancer Institute Study 6/2/2014 6:32:56 AM
Protea Biosciences, Inc. Enters Into Collaborative Research Agreement With The Memorial Sloan-Kettering Cancer Center And The Dana-Farber Cancer Institute 4/30/2014 10:09:12 AM
Link Discovered Between Down Syndrome And Leukemia, Dana-Farber Cancer Institute Study 4/21/2014 7:02:50 AM
Fresenius Kabi AG Scientific Investigator Award Presented To Dana-Farber Cancer Institute 4/2/2014 10:09:04 AM
Sequenta, Inc.’s Clonosight Test To Be Used By The Dana-Farber Cancer Institute/Acute Lymphoblastic Leukemia (ALL) Consortium 2/25/2014 9:39:56 AM
Dana-Farber Cancer Institute Announces $30 Million Gift From Albert A. Marcotte, Phd 1/13/2014 11:18:42 AM
12345678910...
//-->